Evaluation of Access to Screening for Post-partum Depression Via the Postnatal Interview Within 8 Weeks of Birth in Women Who Have Gave Birth at the Troyes Hospital ( DEPRESSIONPP )
DEPRESSIONPP
1 other identifier
observational
400
1 country
1
Brief Summary
Post-partum depression is defined as a depressive disorder with onset of symptoms in the year following childbirth. Several international studies have reported a prevalence of this condition of around pathology of around 15%. Santé publique France's 2021 national perinatal survey corroborated these figures, finding a prevalence of post-partum depression in France of in France of 16.7%. It is therefore a frequent pathology that can cause complications for both mother and child. The complications both for the mother and for the mother-child bond. Indeed, post-partum depression can lead to an increased risk of infanticide, weaker mother-child attachment, and altered parental behaviour. post-partum depression can lead to maternal suicide (the second leading cause cause of maternal mortality in France). Despite the potential seriousness of severe depression and its impact on the on the mother-child bond, just under half of those suffering from severe depression suffering from severe depression consult a healthcare professional. Fear of being judged or stigmatised, linked to misperceptions about the episode, is one of the main obstacles to consultation. Of being judged or stigmatised, linked to erroneous representations of the depressive episode. Given the scale of this condition, and the difficulties young mothers face in seeking help for young mothers to seek help, it is vital to screen postpartum women as widely and post-partum women as early as possible. In view of the extent of this condition and the difficulties young mothers have in seeking help for young mothers, it is vital to screen post-partum women as widely and as post-partum. With this in mind, from July 2022, a compulsory early post-natal interview has been introduced, designed to screen for postpartum depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedFirst Posted
Study publicly available on registry
June 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2024
CompletedJune 21, 2024
June 1, 2024
3 months
May 31, 2024
June 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measure if the patient is yes or not to be referred by a healthcare professional during the early postnatal interview.
question
3 months
Secondary Outcomes (4)
Measure the socio-economic status
3 months
measure the declaration of a financial or non-financial obstacle
3 months
measure the knowledge about post-partum depression
3 months
measure the knowledge about early post-natal interview.
3 months
Interventions
visit post partum
Eligibility Criteria
the adult women who have given birth at the Centre Hospitalier de Troyes between July 2022 and October 2023.
You may qualify if:
- The study will include adult women who have given birth at the Centre hospitalier de Troyes from July 2022 to October 2023
- and agreeing to take part in the study.
- minors under the age of 18
- those protected by law (guardianship, curatorship and safeguard of justice)
- patients refusing to take part in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de Troyes
Troyes, Grand Est, 10000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amjad KATTINI, DR
Centre Hospitalier de Troyes
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2024
First Posted
June 21, 2024
Study Start
March 1, 2024
Primary Completion
June 1, 2024
Study Completion
August 31, 2024
Last Updated
June 21, 2024
Record last verified: 2024-06